Ibogaine Addiction Treatments & MDMA Assisted-Psychotherapy: MINDCURE & The State Of Psychedelic Therapeutics… Nov 23, 2021
Numinus CEO Payton Nyquvest Says Psychedelic Therapy Shouldn’t Be The ‘Last’ Option For Treatment Nov 21, 2021
UCSF Releases Positive Report On Bucillamine’s Ability To Disrupt The Delta Variant And Protect Lungs In Vivo Nov 17, 2021
CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
InMed Pharmaceuticals Makes Noise With Patent Application & Acquisition: Cannabis Stock Investing Nov 9, 2021
